Evidence map›Paper›PMID 14738570›Full record

ArticleBMC cell biology2004

Fas induces apoptosis in human coronary artery endothelial cells in vitro.

Gerasimos Filippatos, Edmund Ang, Claudia Gidea, Erhan Dincer, Rongqi Wang, Bruce D Uhal

Open access · goldAbstract read
In one paragraph

Article in BMC cell biology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Understanding endothelial cell apoptosis: what can the transcriptome, glycome and proteome reveal?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2007
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 2 countries.

Gerasimos FilippatosSecond Division of Cardiology, Evangelismos General Hospital, Athens, Greece. geros@compulink.gr
Edmund Ang
Claudia Gidea
Erhan Dincer
Rongqi Wang
Bruce D Uhal
Abbott Fund · USCardiovascular Institute of the South · USEvangelismos Hospital · GRMedical College of Wisconsin · USMercy Hospital and Medical Center · USMichigan State University · US

Funding

CONTROL OF TYPE II PNEUMOCYTE PROLIFERATIONR01HL045136 · NHLBI · RUSH UNIVERSITY MEDICAL CENTER · PI UHAL, BRUCE D · 1996 to 2012
$2.9M
CONTROL OF TYPE II PNEUMOCYTE PROLIFERATIONR29HL045136 · NHLBI · RUSH UNIVERSITY MEDICAL CENTER · PI UHAL, BRUCE D · 1990 to 1994
–
NHLBI NIH HHS HL-45136NHLBI NIH HHS R01 HL045136
6 · The paper itself

Abstract

backgroundPublished work suggests that some types of endothelial cells undergo apoptosis in response to ligation of the receptor Fas (CD95, APO1) but other types are resistant. Because heterogeneity among endothelial cells from different tissues, has been demonstrated, the purpose of this study was to determine, if Fas ligation and/or activation by human Fas ligand induces apoptosis and caspase activities, in cultured human coronary artery endothelial cells, and the differences between TNF-a and FAS induced apoptosis in these cells.

resultsCultured human coronary artery endothelial cells (HCAEC) were exposed to the monoclonal Fas-activating antibody CH-11, to purified recombinant human Fas ligand, to the Fas-neutralizing antibody ZB4, or to purified recombinant human TNF-alpha. Apoptosis was detected by assessment of chromatin condensation and nuclear fragmentation and by assay of the enzymatic activities of Caspase 1 and Caspase 3 with membrane-permeable substrates applied to intact cells. Fas protein was detected by immunoblotting of HCAEC lysates. Apoptosis was induced in HCAEC by purified Fas ligand or by the monoclonal activating antibody CH-11 at concentrations of 25 or 200 ng/ml, but not by nonspecific isotype-matched immunoglobulins. The apoptotic index elicited by either Fas activator was equal to that induced by TNF-a (3.0-3.6-fold versus control, p < 0.01). The Fas-neutralizing antibody ZB4 abrogated HCAEC apoptosis induced by CH-11, but had no inhibitory effect on apoptosis in response to TNF-a. Fas ligation significantly increased the activities of both Caspase 1 and Caspase 3 at 20 hours of stimulation (1.7- and 2.0-fold versus control, both p < 0.05); in contrast, purified TNF-a increased the activity of Caspase 3 but not Caspase 1 (2.1-fold, p < 0.05). Western blotting of HCAEC lysates with antibody CH-11 identified a single immunoreactive protein of 90 kDa.

conclusionsCultured human coronary artery endothelial cells express functional Fas capable of inducing apoptosis in response to either purified Fas ligand or receptor-activating monoclonal antibodies, at levels equal to those inducible by purified TNF-alpha. Immunologic studies and differential kinetics of caspase activation suggest that Fas and TNF-alpha induce apoptosis in HCAEC by signaling pathways that are distinct but equal in potency.

Indexed as

ApoptosisCaspasesCells, CulturedCoronary VesselsEndothelium, VascularFas Ligand Proteinfas ReceptorHumansMembrane GlycoproteinsTumor Necrosis Factor-alphaCaspasesFASLG protein, humanFas Ligand Proteinfas ReceptorMembrane GlycoproteinsTumor Necrosis Factor-alpha

Identifiers

PMID14738570
PMCPMC331398
OpenAlexW1783516661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.